Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
The endocannabinoid system (ECS) is composed of the two canonical receptor subtypes; type-1 cannabinoid (CB1R) and type 2 receptor (CB2R), endocannabinoids (eCBs) and enzymes responsible for the synthesis and degradation of eCBs. Recently, with the identification of additional lipid mediators, enzym...
Main Authors: | Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, Emmanuel S. Onaivi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.828895/full |
Similar Items
-
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
by: Berhanu Geresu Kibret, et al.
Published: (2022-01-01) -
Editorial: Unravelling the role of CB2r in neuropsychiatric diseases
by: Emmanuel S. Onaivi
Published: (2023-03-01) -
Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
by: Qing-Rong Liu, et al.
Published: (2020-12-01) -
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
by: Barbara Vuic, et al.
Published: (2022-11-01) -
Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
by: Katelyn Cuttler, et al.
Published: (2021-10-01)